Home Healthcare Devices Market Size, Share, Trends and Forecast 2026 to 2035

Home Healthcare Devices Market is segmented By Therapeutic Devices (Insulin Delivery Systems, Home Dialysis Machines, Respiratory Devices, Others), By Monitoring Devices (Blood Glucose Meters, Blood Pressure Monitors, Temperature Monitoring Devices, Pulse Oximeters, Others), By Mobility Care Devices (Wheelchairs, Walkers, Mobility Scooters, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, South America, and Middle East & Africa) 2026-2035

Last Updated: || Author: Akshay Reddy || Reviewed: Akshay Reddy || SKU: MD8918

Buy any syndicated report and get free complimentary customization of up to 20% of the Report and an interactive dashboard.

Free Dashboard
Report Summary
Table of Contents
List of Tables & Figures

Market Size

2035

USD 95.62 Billion

CAGR (2026-2035)

6.80%

Leading Region

North America

Fastest Growing

Asia-Pacific

Home Healthcare Devices Market Size

The Home Healthcare Devices Market is  reached USD 49.40 Billion in 2025 and is projected to grow to USD 95.62 Billion by 2035, registering steady growth at a CAGR of 6.8% during the forecast period from 2026 to 2035.

Home healthcare devices are a set of medical devices and technologies that individuals can use at home to manage their health conditions. Individuals can use these devices to monitor and treat a variety of medical concerns without making regular visits to healthcare institutions, enabling a more comfortable and convenient approach to healthcare. The growing demand for home-based care reflects a larger trend in the healthcare sector, in which people want to keep their independence while obtaining necessary medical treatment. 

The increased patient demand for home-based treatments is the driving factor that drives the market over the forecast period. Several factors contribute to this move toward home healthcare, including an aging population, an increase in the prevalence of chronic diseases, and developments in medical technology that improve the feasibility and effectiveness of home-based care.

Home Healthcare Devices Market Key Takeaways

  • The market generated USD 49.40 billion in 2025 and is expected to approach USD 95.62 billion by 2035, reflecting sustained demand for home-based healthcare solutions.
  • Monitoring devices continue to represent the largest revenue opportunity as healthcare providers increasingly adopt continuous patient monitoring for chronic disease management.
  • North America maintains market leadership due to mature healthcare infrastructure, high technology adoption, and the presence of leading medical device manufacturers.
  • Asia-Pacific is expected to record the fastest expansion, supported by rapidly aging populations, increasing chronic disease incidence, and improving healthcare accessibility.
  • Artificial intelligence, smartphone-enabled monitoring, and remote patient management platforms are becoming important competitive differentiators across device manufacturers.
  • Product innovation continues to focus on connected healthcare ecosystems that reduce hospital admissions while improving patient compliance and clinical outcomes.
  • Companies investing in digital connectivity, wearable monitoring technologies, and integrated home healthcare platforms are likely to strengthen their competitive positioning over the forecast period.

Home Healthcare Devices Market Scope

MetricDetails
Market Size (2025)USD 49.40 Billion
Forecast Market Size (2035)USD 95.62 Billion 
CAGR6.80%
Historic Years2023-2024
Base Year2025
Forecast Period2026-2035
Segments CoveredTherapeutic Devices, Monitoring Devices, Mobility Care Devices, Distribution Channels
Leading RegionNorth America
Fastest Growing RegionAsia-Pacific

For more details on this report – Request for Sample

Home Healthcare Devices Market Dynamics: Drivers & Restraints

Increased patient demand for home-based treatments

The increased patient demand for home-based treatments is expected to be a significant factor in the growth of the global home healthcare devices market. This trend is primarily fueled by several interconnected factors, including the aging population, the rising prevalence of chronic diseases, and advancements in technology, introduction of artificial intelligence in devices that facilitate effective care at home. The expanding geriatric population has a substantial impact on the global home medical equipment market, owing to older persons' specific healthcare needs. As people age, they are more likely to develop chronic diseases that require continuing medical treatment and monitoring. 

The increase in the geriatric population is one of the major reasons for the increasing demand of home-based treatment. For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over.

The technological advancements, recent launches, and FDA approvals of various devices drives the market. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Moreover, in September 2024, Abbott Laboratories announced that its over-the-counter continuous glucose monitor Lingo is available in the U.S. One of Abbott’s primary goals is to help Lingo users learn about glucose spikes, which occur when the amount of sugar present in the bloodstream rapidly increases and then decreases.

High costs of devices

Factors such as high costs of devices are expected to hamper the global home healthcare devices market. The high cost of medical devices is a major concern for potential consumers. Many home healthcare products, such as insulin pumps, nebulizers, and advanced monitoring systems, come with high prices that may hinder patients from purchasing them. This is especially true in areas where insurance coverage for such devices is low or non-existent, requiring patients to face the entire expense themselves. For instance, the average price of the insulin delivery system ranges from $3,000 to $ 6,000. This highlights the substantial cost burden that people suffer when using these vital devices.

Home Healthcare Devices Market Segment Analysis

The global home healthcare devices market is segmented based on therapeutic devices, monitoring devices, mobility care devices, distribution channels, and region.

Monitoring devices segment is expected to dominate the global home healthcare devices market share

The monitoring devices segment is anticipated to dominate the global home healthcare devices market. The monitoring devices segment is expected to lead the worldwide home healthcare devices market due to several interconnected variables that represent the changing face of healthcare. As chronic diseases become more common, there is an increased demand for ongoing health monitoring, particularly among older persons and those with long-term health concerns. This shift toward proactive health management stresses the relevance of patient monitoring devices, which enable people to follow vital signs and other health metrics from home, allowing for more prompt interventions and lowering the need for hospital visits.

For instance, in August 2024, Dexcom announced the launch of an over-the-counter continuous glucose monitor. Dexcom's Stelo monitors blood glucose levels constantly via a wearable sensor and an application on the user's smartphone or other smart device. 

Moreover, in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, Pylo GL1-LTE. The blood glucose meter has been scientifically tested and linked to numerous cellular networks to guarantee more dependable data transmission across the United States. The GL1-LTE is compatible with the Prevounce remote care management platform and may be integrated with other health software using the Pylo cloud API. Prevounce's Pylo cellular-connected gadgets include blood pressure monitors and weight scales.

Home Healthcare Devices Market Geographical Share

North America is expected to hold a significant position in the global home healthcare devices market share

North America is expected to hold a significant portion of the global home healthcare devices market. North America will likely dominate the global home healthcare devices market, owing to a combination of demographic, economic, and technical factors. The region benefits from a well-established healthcare infrastructure that encourages the use of home healthcare solutions. As the geriatric population and frequency of chronic diseases increases, so does the demand for home medical equipment that enables patients to properly manage their health conditions from the comfort of their own homes. This trend to home-based treatment not only improves patient comfort but also decreases the pressure on healthcare facilities, making it a popular choice among many individuals and families.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population. 

There are major players present in this region which makes this region the most dominating. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy. 

Asia Pacific is growing at the fastest pace in the global home healthcare devices market 

The Asia Pacific region is emerging as the fastest-growing market for home healthcare devices. One of the major contributions to this growth is the rising prevalence of chronic diseases in the population and the increasing geriatric population. Diabetes, cardiovascular diseases, and respiratory ailments are growing increasingly prevalent as people's lifestyles change and urbanization accelerates. The rise in chronic diseases demands continual monitoring and management, making home medical devices crucial for individuals who prefer to manage their health at home rather than visit healthcare facilities. 

The increasing geriatric population is one of the driving factors in this region, making it the fastest-growing region. For instance, according to the UNFPA India, the current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050. 

Home Healthcare Devices Market Global Players

The major global players in the global home healthcare devices market include Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation, Danaher Corporation among others.

Home Healthcare Devices Market Emerging Players

Livongo, Tyto Care, and iRhythm Tech among others

Home Healthcare Devices Market Key Developments

  • April 2026 – Rising adoption of remote patient monitoring devices
    Companies such as Invacare, Medtronic, and Philips expanded remote monitoring solutions, including wearable sensors and home-based diagnostic devices, enabling continuous patient tracking and reducing hospital visits.
  • March 2026 – Growth in respiratory care devices for home use
    Key players like Koninklijke Philips N.V., Nihon Kohden, and Medtronic increased focus on oxygen concentrators, CPAP, and BiPAP devices as demand for at-home respiratory support continues to grow.
  • February 2026 – Expansion of mobility and rehabilitation devices
    Companies such as Sunrise Medical, Ottobock, and Pride Mobility introduced advanced wheelchairs, mobility scooters, and rehabilitation equipment to support aging populations and post-surgery recovery.
  • January–April 2026 – Increased demand for home diagnostic and monitoring equipment
    The market is witnessing strong demand for devices like blood pressure monitors, glucometers, and patient monitoring systems, driven by chronic disease management and home-based healthcare trends.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global home healthcare devices market report delivers a detailed analysis with 60+ key tables, more than 50  visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2026

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, advocacy groups, and insurance companies.
  • Academic & Research: Academic Institutions. 

Conclusion

The Home Healthcare Devices Market is positioned for sustained expansion as healthcare delivery increasingly shifts from hospitals to patient homes. Long-term demographic changes, growing chronic disease prevalence, digital health adoption, and continued innovation in connected monitoring technologies are expected to support market growth through 2035. Organizations that combine reliable medical devices with intelligent software platforms, remote patient management capabilities, and accessible pricing strategies are likely to strengthen their market position. Decision-makers across manufacturing, healthcare delivery, investment, and technology sectors should closely monitor this market as home-based healthcare continues becoming an integral component of modern healthcare systems.

Save 31% on all licenses
Single User$4350$2999Corporate$7850$5412

Free 20% customization + dashboard

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • The global Home Healthcare Devices market was valued at USD 49.40 billion in 2025 and is projected to reach USD 95.62 billion by 2035, growing at a CAGR of 6.8% during the forecast period.

  • Key players are Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation and Danaher Corporation.

  • The market is driven by the growing aging population, increasing prevalence of chronic diseases, rising demand for home-based care, advancements in connected medical devices, remote patient monitoring technologies, and expanding adoption of digital healthcare solutions.

  • Monitoring devices account for the largest market share, driven by rising demand for continuous monitoring of chronic conditions such as diabetes, hypertension, cardiovascular diseases, and respiratory disorders.

  • Major challenges include the high cost of advanced home healthcare devices, limited reimbursement coverage in some countries, lack of awareness in developing regions, cybersecurity concerns related to connected devices, and regulatory compliance requirements.

  • Technologies such as artificial intelligence, Internet of Things (IoT), wearable sensors, smartphone connectivity, cloud-based remote monitoring, and telehealth integration are improving patient monitoring, enabling early intervention, and enhancing clinical outcomes.

  • Key opportunities include AI-powered remote patient monitoring, wearable medical devices, connected home healthcare ecosystems, digital therapeutics, smart mobility devices, home diagnostics, and expanding healthcare access across emerging markets.

  • Manufacturers face challenges including high development costs, strict regulatory requirements, data privacy and cybersecurity concerns, device interoperability issues, reimbursement limitations, and increasing competition from digital health companies.

  • Telehealth enables virtual consultations and seamless integration with connected medical devices, allowing healthcare professionals to monitor patients remotely, improve treatment compliance, reduce healthcare costs, and expand access to quality care.

  • Key trends include expanding remote patient monitoring, AI-enabled healthcare devices, connected wearable technologies, home diagnostics, smartphone-integrated medical devices, digital health ecosystems, aging populations, and increasing demand for personalized home-based healthcare solutions.
What Our Clients Say About this Report
Dr. Matthew Collins
Director of Home Healthcare Solutions
17 Jun, 2026
5/5
DataM Intelligence's Home Healthcare Devices Market report provided our team with a comprehensive understanding of the rapidly evolving home-based care landscape. The detailed analysis of therapeutic devices, patient monitoring technologies, mobility care solutions, market trends, competitive landscape, and regional growth opportunities enabled us to make well-informed strategic decisions. The report's data-driven insights and actionable recommendations proved invaluable for our product development and expansion plans.
Jennifer Adams
Vice President, Digital Health Strategy
25 Feb, 2026
5/5
The Home Healthcare Devices Market report from DataM Intelligence delivered exceptional market intelligence with the level of detail our organization was seeking. The report effectively covered technological advancements, remote patient monitoring trends, aging population dynamics, distribution channels, and competitive developments across the global market. Its well-structured forecasts and strategic insights helped us validate growth opportunities and strengthen our long-term business strategy.
PDF
DataM
Home Healthcare Devices Market Report
SKU: MD8918

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports